Skip to main content

Current Funding Announcements

See below

Combat Readiness – Medical Research Program Rapid development and translational research award (RDTRA)

 
Description: The CRRP focuses on forward-deployable solutions that can promptly address life- 
threatening injuries, medical threats, and treatments for Warfighters in current and future 
battlefield settings, to deliver high-impact medical solutions in diverse operational settings and 
closer to the point of injury to increase survivability and Warfighter readiness. The program seeks 
to develop innovative solutions to increase medical readiness, mitigate fatalities, optimally treat 
life-threatening injuries, and promote positive long-term outcomes.  Innovations developed by 
CRRP-supported research may be applied proactively as a way to establish medical readiness ahead of 
deployment, in operational settings at the point of injury, during periods of prolonged care, or 
during transport/ en route between roles of care.
Focus Areas broadly describe current priorities to improve readiness for delivering frontline care 
in combat situations and for delivering medical damage control capability, assets, and life- saving 
interventions during prolonged and en route care in austere and combat environments, including the 
acute and early management of combat-related trauma at the point of injury.
Proposed research must address at least one of the FY22 CRRP Focus Areas; these include 
complementary health measures to accelerate return to duty, and regenerative medicine. Focus areas 
include solutions to enhance combat care delivery throughout the far-forward environment, such as:
•    Telemedicine solutions that enable medical capabilities at far-forward battlespace locations 
worldwide
•    Medical simulation technology that supports sustainment of critical skills and medical 
decision-making
•    Solutions for the assessment of mild traumatic brain injury, to include portable and handheld 
devices
 
Proposed research must have the potential for rapid development and translation of applicable 
advances for improving medical readiness, mitigating fatalities, optimally treating life- 
threatening injuries, and promoting positive long-term outcomes for military health and medicine, 
as well as the general public. Supports preclinical research, clinical research, and small-scale 
clinical trials (e.g., first in human, phase 1/1b).


Pre-Application (Preproposal) due: June 23, 2022
Proposal/Application due: September 14, 2022
Max Period of Performance: 2 years (3 years with option)
Max Funding: $2.2M total costs (2 years), $1M option year

 

For more information, full announcements (extramural, intramural), and submission
 

Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Hearing Restoration Research Program (HRRP) – Anticipated Funding Opportunities for FY22

 
PRE-ANNOUNCEMENT: Department of Defense Congressionally Directed Medical Research Programs (CDMRP) 
Hearing Restoration Research Program (HRRP) – Anticipated Funding Opportunities for FY22

 

Description: The FY22 Defense Appropriations Act provides funding for the Hearing Restoration 
Research Program (HRRP) to support innovative and impactful research that pursues the treatment of 
auditory system injuries and the restoration of hearing. The HRRP is providing the information in 
this pre-announcement to allow investigators time to plan and develop ideas for submission to the 
anticipated FY22 funding opportunities. This pre-announcement should not be construed as an 
obligation by the government. The FY22 HRRP funding opportunity announcements for the following 
award mechanisms will be posted on the Grants.gov website. Pre-application and application 
deadlines will be available when the announcements are released.
 
Applications submitted to the FY22 HRRP must address one or more of the following Focus Areas:
 
•     Accelerate translation of biological regeneration/repair mechanisms into therapies that treat 
auditory system injury and restore auditory function.
For example, but not limited to:
     o  Hair cell regeneration/repair/recovery
     o  Neural regeneration/repair/recovery
     o  Treatment for synaptopathy and hidden hearing loss
•     Diagnostic tests that help differentiate sensory, neural, synaptic, and central processing 
disorders, that may inform applicability and outcomes for current or future hearing restoration 
therapeutics.
•     Develop reliable in-vitro human models to facilitate the understanding, derivation and 
characterization of human auditory cells, and/or to facilitate the evaluation of hearing 
restoration therapies.
•     Develop and/or validate techniques/methods beyond the audiogram to diagnose acute auditory 
system injury in austere or remote environments. For example, but not limited to, simple and rapid 
assessments that are compatible with portable platforms.
 
A pre-application is required and must be submitted through the electronic Biomedical Research 
Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All 
applications must conform to the final funding opportunity announcements that will be available for 
downloading from the Grants.gov website. The application package containing the required forms for 
each award mechanism will also be found on Grants.gov.
 

 

Maximum funding/periods of performance
Funding level 1: $250,000/2 years
Funding level 2: $1M/3 years
Funding level 3: $1.25M/3 years

 

Point of Contact: CDMRP Public Affairs, 301-619-9783, usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil
 

FY22 Department of Defense, Defense Health Program, Congressionally Directed Medical Research Programs (CDMRP) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA)

 
W81XWH-22-S-JWMRP/ W81XWH-22-JWMRP-MMRDA: FY22 Department of
Defense, Defense Health Program, Congressionally Directed Medical Research Programs (CDMRP) Joint 
Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA)
Description: The JWMRP was initiated in 2012 to augment and accelerate high-priority Department of 
Defense (DOD) and Service medical requirements and to continue prior year initiatives that are 
close to achieving their objectives and yielding a benefit to military medicine. The ultimate goal 
of the program is to expedite the delivery of highly impactful medical solutions to Service Members 
and Military Health System (MHS) beneficiaries. Funds from the JWMRP shall not be used for new 
projects or for basic research.

 

To be eligible for JWMRP funding, applicants must have already received DOD core or DOD 
Congressional Special Interest prior year funding (including DOD Small Business Innovation 
[SBIR]/Small Business Technology Transfer [STTR] awards) for the same project proposed for 
continuation under this MMRDA.

 

Focus Areas of interest include:
• Operational Medicine and Readiness
     o  Research aimed toward injury prevention, rapid return-to-duty capabilities, and rehabilitation 
     solutions to maintain Service Member readiness (musculoskeletal and neurosensory)
     o  Mechanism-based criteria and injury prediction models for ballistic and/or blast- induced head 
     injuries from a wide range of loading regimes seen with current and likely future weapons systems, 
     with the goal of informing the development of more effective helmet protection

 

Find information for extramural and intramural applicants at: https://cdmrp.army.mil/funding/jwmrp

 

Pre-Application (Preproposal) Deadline: May 16, 2022
Application Deadline:  July 28, 2022 11:59 p.m. ET

 

Maximum funding: $4.5 million for total costs
Maximum period of performance: 3 years

 

CDMRP Help Desk: help@eBRAP.org
 

FY22 CDMRP Peer Reviewed Medical Research Program Awards

W81XWH-22-PRMRP – FY22 CDMRP Peer Reviewed Medical Research Program
Awards
•     Clinical Trial Award (CTA)
•     Discovery Award (DA)
•     Focused Program Award (FPA)
•     Investigator-Initiated Research Award (IIRA)
•     Technology/Therapeutic Development Award (TTDA)
Description: The PRMRP is committed to supporting research that has the potential to profoundly 
impact the development and implementation of medical devices, drugs, and clinical guidance that 
will enhance the precision and efficacy of prevention, diagnosis, and treatment across a wide range 
of disciplines including autoimmune diseases and immunology, cardiovascular health, endocrine 
health and metabolism, environmental health, infectious diseases, internal medicine, neurological 
and psychological health, orthopedic and regenerative medicine, and respiratory health and injury.
 
FY22 PRMRP Portfolio Categories/Topic Areas/Strategic Goals include Neuroscience /Trauma:
 
•     Foundational Studies: mechanisms underlying neurological diseases and psychological 
conditions including potential relationships to environmental/neurotoxic exposures, injury, stress, 
or infections
•     Prevention: strategies, including predictive analytics and artificial intelligence, to 
provide early identification of associated neurological diseases and psychological conditions, with 
the goal of providing early intervention; tools to reduce complications of physical and/or 
psychological trauma
•     Treatment: novel treatments, strategies or therapeutic targets, including research to 
repurpose existing drugs, for associated neurological diseases and psychological conditions; 
capabilities to monitor, and therapies or countermeasures to maintain, optimal cognitive 
functioning and mental resilience; treatment strategies to manage symptoms and improve quality of 
life for those affected by associated neurological and psychological conditions
•     Epidemiology: population-based studies to identify risk factors (e.g., military-specific 
lifestyle) that contribute to onset and progression of associated neurological diseases and 
psychological conditions
 
Program announcements, instructions, and pre-application: https://cdmrp.army.mil/funding/prmrp
 
All pre-applications must be submitted electronically to the Electronic Biomedical Research 
Application Portal (eBRAP) https://ebrap.org. Full applications must be submitted electronically to 
the Grants.gov website https://grants.gov.
 

BRAIN Initiative: Targeted BRAIN Circuits Projects – Targeted BCP (R01 Clinical Trial Not Allowed)

RFA-NS-22-026: BRAIN Initiative: Targeted BRAIN Circuits Projects – Targeted BCP (R01
Clinical Trial Not Allowed)
Description: This FOA solicits applications for research projects that seek to understand how 
circuit activity gives rise to mental experience and behavior using innovative, methodologically- 
integrated approaches. The goal is to support adventurous projects that can realize a potentially 
transformative outcome within 5 years. Applications are expected to address circuit function in the 
context of specific behaviors or neural systems, such as sensation, perception, attention, 
reasoning, intention, decision-making, emotion, navigation, communication, or homeostasis. Projects 
should link theory, data analysis, and/or computational approaches to experimental design and 
should produce predictive models (conceptual or quantitative).
Projects should aim to improve the understanding of circuits of the central nervous system by 
systematically controlling stimuli and/or behavior while actively recording and/or manipulating 
dynamic patterns of neural activity. Diverse species or experimental systems and a cross- 
species/comparative approach are welcome and should be chosen based on their power to address the 
specific question at hand and to reveal generalizable and fundamental neuroscience principles.
Targeted BRAIN Circuit Project R01 awards will support an individual laboratory or a small 
multi-PD/PI team. Projects should reflect the NIH BRAIN Initiative interests of the application of 
cutting-edge methodologies to understand central nervous system circuit function and
dynamics at cellular and sub-second levels of resolution in ethologically relevant behaviors of an 
organism or a well-defined neural system. Applications should offer specific, feasible, and 
potentially transformative research goals as endpoints within a 5-year term

 

Representative topics include: Innovative approaches to understand network coding of sensory 
information and/or multi-sensory integration, at multiple stages of processing, in response to 
naturalistic inputs and perceptual contexts.

 

Letter of Intent due date(s) 30 days prior to the application due date
 
Application due dates: June 1, 2022; July 1, 2022; October 6, 2022; June 30, 2023; October 4,
2023; June 28, 2024; October 2, 2024
 
Maximum project period: 5 years
 
Funding amount: the BRAIN Initiative intends to commit up to an estimated total of $15 M per year 
to fund 20 awards.

Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-026.html

 

American Hearing Research Foundation Discovery Grants

American Hearing Research Foundation: Hearing and Balance Disorders of the
Inner Ear and Related Topics

Description

AHRF Discovery Grants (formerly called Regular Grants) funds studies that investigate various 
aspects of hearing and balance disorders related to the inner ear. AHRF typically funds six to ten 
Discovery Grants each year. Priority is given to investigators early in their careers who need seed 
funds to generate results and data that can be used to support applications for larger grants 
(i.e., NIH grants) in the future.
The Birtman Grant may be awarded for exceptional scientific investigation when AHRF identifies a 
study that shows outstanding promise.
Both basic and clinical studies may be proposed that investigate aspects of the auditory and 
vestibular systems including but not limited to:
 
•    genetics
•    neurotology
•    anatomy
•    auditory processing
•    molecular and cellular biology
•    therapeutic studies
•    investigations of current or experimental devices (i.e., cochlear implants)
 
AHRF donors have given special support for research that explores Meniere’s disease (mechanisms, 
causes, or treatments) and the causes or mechanisms of sudden hearing loss. Proposals that address 
these areas of interest will receive special consideration during the review process.
 
Applicants must hold an MD, PhD, AuD, or equivalent degree(s) and be associated with a university 
or hospital in the United States.
Next deadline: August 16, 2021
Maximum Project Period: 1 year (1/1/2022 – 12/31/2022)
Maximum Amount: $50,000 (Discover Grant), $75,000 (Birtman Grant)

 

Additional Information: https://www.american-hearing.org/research-grants/grants-we-offer/

https://www.american-hearing.org/research-grants/grant-process/

 

NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trials Optional)

RFA-DC-22-001: NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trials Optional)
NIH - National Institute on Aging (NIA) and National Institute on Deafness and Other Communication 
Disorders (NIDCD)
Description: This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic 
scientists, clinicians and clinical scientists to jointly initiate and conduct translational 
research projects which translate basic research findings into clinical tools for better human 
health. The scope of this FOA includes a range of activities to encourage translation of basic 
research findings which will impact the diagnosis, treatment and prevention of communication 
disorders.  Connection to the clinical condition must be clearly established and the outcomes of 
the grant must have practical clinical impact.


Possible goals include, but are not limited to:

 
•     Biochemical, electrophysiological and behavioral assays to enhance diagnostic capabilities.
•     Pharmacology, toxicity, and pharmacokinetic for candidate therapeutics that have demonstrated 
potential for the treatment of communication disorders.
•     Preclinical animal research for dosage studies and toxicity when a subsequent Phase I/II 
clinical trial is planned.
•     Translation of new tools and techniques for better diagnostics or therapeutics, including but 
not limited to, neuroprosthetic devices, drug delivery devices, neuro-electrical stimulators and 
recording devices.
•     Translation of laboratory-based screening tests, including biomarkers into improved ways to 
identify individuals at risk for a communication disorder to allow for early intervention.
•     Translation of published basic research findings into new clinical tools to better target the 
treatment to the individual patient and to better predict patient response or prognosis.
•     Translation of discoveries from biological, psychological, social sciences and other related 
areas into innovative prevention and treatment paradigms and processes.
•     Modification of laboratory measures of function or laboratory treatment protocols for use in 
clinical settings.
 
Open Date (Earliest Submission Date): September 17, 2021
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date(s): October 20, 2021; June 20, 2022; February 22, 2023; October 18,
2023; June 20, 2024
Maximum Project Period: 5 years
Maximum Amount: NIDCD anticipates funding an estimated 2-3 awards in fiscal year 2022 for a total 
of $1,500,000.
 

Open/Active DoD Broad Agency Announcements

U.S. Army Medical Research and Development Command (USAMRDC) - W81XWH18SBAA1: This BAA is open through September 30, 2022. USAMRDC funds a broad range of extramural research programs through contracts, grants, or cooperative agreements. Proposals can be submitted through the USAMRDC Broad Agency Announcement (BAA) or through special USAMRDC BAA Announcements, which are open for limited timeframes. Additional information, the USAMRDC Broad Agency Announcement, and open special USAMRDC BAA Announcements can be obtained at:  https://www.usamraa.army.mil/Pages/BAA.aspx and https://www.grants.gov/web/grants/view-opportunity.html?oppId=297726

U.S. Air Force/AFRL - 711 HPW BAA: The Airman Readiness Medical Research (ARMR) Hybrid Broad Area Announcement (BAA) was released May 1, 2020, and will remain open for 72 months for medical research to optimize the warfighter by enabling, enhancing, restoring, and sustaining the Airman to more effectively execute the Air Force mission. This medical research objective aims to: (1) ensure medical availability of Airmen by analyzing attributes (sensory, behavioral, physiologic) and operational environments (chemical, physical, psychological, biological, radiological stressors) to drive optimal performance of Airmen engaged in high-demand, high-impact mission tasks (2) investigate how the flight environment affects the process of life, the ability to maintain homeostasis, and the risk for injury or secondary insult, seeking to ameliorate these stressors to optimize Airman health and performance.

             See:  https://beta.sam.gov/opp/31a536d407cd4d519fc89ffd3366cbb3/view?keywords=AirmanReadinessMedicalResearch(ARMR)&sort=relevance&index=&is_active=true&page=1

      

U.S. Air Force/AFRL - BAA-AFRL-RQKHC-2016-0009 Aerospace Medicine, Clinical Research, Human Performance Research, and Expeditionary Medicine: This BAA will remain open for seventy-two (72) months with calls being released throughout the seventy-two (72) month period of performance.  The Air Force Research Laboratory (AFRL) 711 Human Performance Wing in the School of Aerospace Medicine and Human Systems Integration Directorate solicits innovative research proposals in the following five research areas.
1. Force Health Protection – Focus on research to prevent injury and illness and the early recognition or detection of emerging threats. 2. EN Route Care –Continuum of care during transport of patients from point of injury to point of definitive care.
3. Operational Medicine (OM) – Air Force Medical Service (AFMS) sponsored OM encompasses interest in definitive diagnosis, care, and treatment in-garrison, to ensure the highest quality of healthcare for active duty members and their families.
4. Expeditionary Medicine - Improving expeditionary medical care during contingency operations including medical countermeasures against combat and operational stressors to maximize warrior health, performance, and well-being.
5. Human Performance and Systems Integration - Maximizing operational human performance for a fit and healthy force.

             See: https://beta.sam.gov/opp/4eebfe8f580a41e8a32ba4eae5920342/view?keywords=AerospaceMedicine,ClinicalResearch,HumanPerformanceResearch,andExpeditionaryMedicine&sort=-relevance&index=&is_active=true&page=1

 

U.S. Military Academy Broad Agency Announcement - W911NF-20-S-0008: This BAA was released April 1, 2020, and is open until March 31, 2025. It seeks proposals for cutting- edge innovative research that could produce discoveries with significant impact to enable new and improved Army technologies and related operational capabilities in the areas of socio-cultural; information technology; ballistics, weapons and protections; energy and sustainability; materials, measurements, and facilities; unmanned systems and space; human support systems; and artificial intelligence, machine learning, and quantum technologies. The human support systems focus includes biomechanical engineering to enhance soldier readiness (human performance optimization, injury prediction/prevention, physical and cognitive augmentation, Return-to-Duty metrics, functional influence of prosthetics/exoskeletal devices) and wearable technologies and sensors to inform performance decisions (e.g., monitoring/assessment, injury prevention, recovery times). 

              See:  Military Academy BAA

NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders

NOT-DC-20-008: NIDCD is Interested in Supporting Research on the Impact of

COVID-19 on Mission Specific Sensory and Communication Disorders

 

Notice of Special Interest (NOSI) issued by the National Institute on Deafness and Other

Communication Disorders (NIDCD) (see: https://grants.nih.gov/grants/guide/notice-files/NOT-DC20-008.html)

 

NIDCD invites applications for research on COVID-19 in relation to NIDCD’s scientific programs of hearing, balance, taste, smell, voice, speech, and language. Given the early stage of COVID19 research, it is critical that there is a strong premise for research proposals submitted in response to this NOSI. When appropriate, NIDCD encourages multi-disciplinary approaches to move the research beyond in vitro and animal models. Areas of research encouraged through this NOSI include, but are not limited to:

 

  • Short- and long-term effects of COVID-19 on the auditory, vestibular, or olfactory systems
  • The prevalence, onset, and resolution of acquired deficits (i.e. HBTSVSL) among patients

    with COVID-19 across the lifespan and in association with various underlying genetic predispositions and health conditions

  • Potential ototoxicity from therapeutics or vaccination related to COVID-19
  • Worsening of communicative function because of physical distancing, sheltering in place,

    and wearing of protective personal equipment during mitigation of this infectious pandemic

  • Telehealth service delivery to individuals with communication disorders
  • Multidisciplinary collaborative teams including clinicians, basic biologists, geneticists,
    quantitative scientist, epidemiologists, or other researchers to study COVID-19 related
    human conditions and behaviors, bioethical considerations, health-service delivery,
    health services in low-resource areas, and health disparities within NIDCD mission areas

 

This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2022. Submit applications for this initiative using one of the following funding opportunity announcements or any reissues of these announcement through the expiration date of this notice: PA-18-334, PA-20-185, PA-20-184, PA-20-196, PA-20-195, PA-20-194, PA-19-270, PA-19-271, PA-19-273, PA-19-272.

 

For funding consideration, applicants must include “NOT-DC-20-008” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.

 

Scientific/Research Contact:

 

Bracie Watson, Jr. Ph.D.

NIDCD/Division of Scientific Programs

Telephone: 301-402-3458

Email: watsonb@nidcd.nih.gov

broad agency announcement (baa) for extramural biomedical research and development

Announcement: Grant
Title:  BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical Research and Development
Award Organization: USSOCOM 
Type/Mechanism: Grant
Funding Opportunity Number: W81XWH-18-S-SOC1
Web Site: DoD : https://www.grants.gov/web/grants/view-opportunity.html?oppId=307754 
Expected Number of Awards: 2
Period of Performance:  2 years
Open App: 1 Aug 2018
Close App: 31 Jul 2023
Description: A primary emphasis of the USSOCOM Biomedical, Human Performance, and Canine Research Program is to identify and develop techniques, knowledge products, and materiel (medical devices, drugs, and biologics) for early intervention in life-threatening injuries, prolonged field care (PFC), human performance optimization, and canine medicine/performance. Special Operations Forces (SOF) medical personnel place a premium on medical equipment that is small, lightweight, ruggedized, modular, multi-use, and designed for operation in extreme environments. The equipment must be easy to use, require minimum maintenance, and have low power consumption. Drugs and biologics should not require refrigeration or other special handling. All materiel and related techniques must be simple and effective, and easily modified for commercialization. 

Research areas of interest include:

• Canine Medicine: 
o Sensory Optimization and Protection: The proposed project must develop research oriented toward innovative methods that enhance or conserve SOF canine olfactory, visual, and/or auditory performance during combat operations.

Max Funding: Most projects are anticipated to have a total cost at or below $700,000 (including indirect costs). Projects that have a total cost higher than $700,000 (including Indirect costs) with outstanding scientific merit that meet a critical need may be accepted; however the total cost of these projects are not to exceed $1,500,000 (including Indirect costs). No budget will be approved by the Government exceeding $1,500,000 (including indirect costs).

Research Interests of the Air Force Office of Scientific Research

Announcement: BAA-AFRL-AFOSR-2016-0007
Award Organization: Air Force Office of Scientific Research
Type/Mechanism: Grant
Activity Code: 
Web Site: DoD: http://www.grants.gov/web/grants/view-opportunity.html?oppId=285269
Award Amount: $200,000 - $400,000 encouraged; $7.5M max
PoP: 5 years
Restrictions: None
Rolling Annual Programs: Open until Superseded
Pre-Application Due: Open until superseded
Full App Due: Open until superseded
Notes: For the sensory systems portion of the portfolio a goal is to pursue new capabilities in acoustic analysis, to enhance the intelligibility and usefulness of acoustic information. The primary approach is to discover, develop, and test principles derived from an advanced understanding of cortical and sub-cortical processes in the auditory brain. Included are efforts to model and control effects of noise interference and reverberation, understand the psychoacoustic basis of informational masking, develop new methods for automatic speech detection, classification, and identification, and enable efficient 3D spatial segregation of multiple overlapping acoustic sources.

DOD USAMRMC FY18-FY22 Broad agency announcement for extramural medical research

Announcement: W81XWH18SBAA1
Award Organization: U.S. Army Medical Research and Material Commnad's
Type/Mechanism: Grants Notice
Activity Code: USC, Title 10, Section 2358
Web Site: https://www.grants.gov/web/grants/search-grants.html?keywords=W81XWH18SBAA1
Award Amount:  
PoP: 4 years 
Restrictions: 
Rolling Annual Programs:
Pre-Application Due: Oct 1, 2017
Full Application Due :  September 30, 2022, 11:59 p.m. ET
Notes: Clinical and Rehabilitative Medicine Research Program focus on the innovations required to reset our wounded Service members, both in terms of duty performance and quality of life. Innovations developed from CRMRP-supported research efforts are expected to improve restorative treatments and rehabilitative care to maximize function for return to duty (RTD) or civilian life. 
The CRMRP focuses its efforts on the following research areas: neuromusculoskeletal injury (including limb trauma and amputation), sensory systems impairment (including hearing, balance, tinnitus, and vision), acute and chronic pain, and regenerative medicine.

Quick Fact

#32

Hearing loss can result from exposure to loud noise, physical injury, ototoxic medications, or illness or disease.

About Us

The Hearing Center of Excellence fosters and promotes the prevention, diagnosis, mitigation, treatment, rehabilitation and research of hearing loss and auditory injury. It supports the development, exchange and adoption of best practices, research, measures of effectiveness and clinical care guidelines to reduce the prevalence and cost of hearing loss and tinnitus among Warriors and Veterans. Read more

Hearing Health Challenge For Change

Take the challenge, pledge your commitment, and share your story in the prevention of hearing loss in America today.

The Hearing Center of Excellence is committed to promoting Hearing Loss Programs and Hearing Loss Prevention Initiatives across the DoD. Take the pledge to implement the Comprehensive Hearing Health Program (CHHP) at your local clinic and share with us how it's going for you!

Pledge on Facebook Pledge on Twitter
Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.